+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Amniocentesis Needles Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • PDF Icon

    Report

  • 120 Pages
  • October 2021
  • Region: Global
  • Acute Market Reports
  • ID: 5616071

Industry Outlook


The amniocentesis needles market is set to reach from US$ 166.0 Mn in 2020 to US$ 218.5 Mn by 2029 at a compound annual growth rate (CAGR) of 3.1% during the forecast period from 2021 to 2029. Amniocentesis is frequently performed in prenatal diagnosis to identify any chromosomal abnormalities, neural tube defect and fetal infections during pregnancy. Rising public health awareness and implementation of effective health guidelines pertaining to obstetrics and gynecology drive the amniocentesis needles market growth. 

Optimal length and availability in different gauge increases the popularity of 100 to 150 mm amniocentesis needles among healthcare professionals


100 to 150 mm needles are spearheading the type segment for amniocentesis needles market. The ergonomic features associated with it such as optimal length and availability in different gauge increase its popularity among healthcare professionals for collection of amniotic fluid. Larger than 150 mm needles are gaining huge traction as it enhances safety and ensures less needle punctures during transabdominal amniocentesis fluid collection in obese pregnant women with increased transabdominal thickness. 

Rising public health awareness and affordable healthcare services drive the hospital segment market growth


Hospitals are dominating the end user segment for amniocentesis needles market. The chief contributing factors influencing its market growth are rising public health awareness regarding prenatal diseases and its effective diagnosis and availability of affordable healthcare services pertaining to obstetrics and gynecology. Diagnostic centers will be projecting impressive growth during the forecast period owing to availability of skilled workforce and advanced equipment utilized in prenatal diagnosis.

Rising popularity of prenatal diagnosis and existence of major players together drive the market growth in North America


In 2020, North America held market share of 34.7% and is leading the regional segment for amniocentesis needles market. The important criterions responsible for its dominating market growth are rising popularity of prenatal diagnosis in pregnant women and domicile of market leaders in the region such as CooperSurgical, Inc., Smiths Group, Plc. Medline Industries, Inc. Becton Dickinson & Company etc. Europe held a market share of 31.5% primarily due to effective implementation of health guidelines pertaining obstetrics and gynecology. Supportive regulatory environment provided by the European Medical Agency for the manufacture and sale of amniocentesis needles. Asia Pacific represents 25.2% market share owing to rise in disposable income, developing healthcare infrastructure and highly competitive environment for major players due to emerging local manufacturers of amniocentesis needles.

Historical & Forecast Period


This research report presents the analysis of each segment from 2019 to 2029 considering 2020 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2021 to 2029.

Medical device companies manufacturing amniocentesis needles are Becton Dickinson & Company, Biopsybell Srl, Cook Medical Incorporated, CooperSurgical, Inc., Laboratoire Ccd., Tsunami Medical S.r.l., Medline Industries, Inc., Ri.mos. S.r.l., Smiths Group, Plc. and Rocket Medical, Plc.

Key questions answered in this report

  • Which medical device companies are providing amniocentesis needles for prenatal diagnosis?
  • What are the latest merger, acquisitions and strategic collaboration taking place in amniocentesis needles market?
  • What is the importance of prenatal diagnosis and how is the amniotic fluid collected for initial screening?
  • Why is larger than 150 mm amniocentesis needles becoming popular?
  • Which factors will favor the diagnostic centers market growth in the near future?
  • What factors are related to market growth in developing regions of Asia Pacific and Latin America?


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global AN Market Portraiture
2.2. Global AN Market, by Type, 2020 (US$ Mn)
2.3. Global AN Market, by End User, 2020 (US$ Mn)
2.4. Global AN Market, by Geography, 2020 (US$ Mn)
Chapter 3. Amniocentesis Needles (AN) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2020
3.6. Competitive Analysis: Global AN Market, by Key Players, 2020
Chapter 4. Global Amniocentesis Needles (AN) Market, by Type
4.1. Overview
4.2. Smaller than 100 mm
4.3. 100 to 150 mm
4.4. Larger than 150 mm
Chapter 5. Global Amniocentesis Needles (AN) Market, by End User
5.1. Hospitals
5.2. Diagnostic Centers
5.3. Clinical Research Institutes
Chapter 6. Global Amniocentesis Needles (AN) Market, by Geography
6.1. Overview
6.2. North America AN Market Analysis, 2019- 2029
6.2.1. North America AN Market, by Type, 2019 - 2029 (US$ Mn)
6.2.2. North America AN Market, by End User, 2019 - 2029 (US$ Mn)
6.2.3. North America AN Market, by Country, 2019 - 2029 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe AN Market Analysis, 2019 - 2029
6.3.1. Europe AN Market, by Type, 2019- 2029 (US$ Mn)
6.3.2. Europe AN Market, by End User, 2019 - 2029 (US$ Mn)
6.3.3. Europe AN Market, by Country/Region, 2019 - 2029 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific AN Market Analysis, 2019 - 2029
6.4.1. Asia Pacific AN Market, by Type, 2019 - 2029 (US$ Mn)
6.4.2. Asia Pacific AN Market, by End User, 2019- 2029 (US$ Mn)
6.4.3. Asia Pacific AN Market, by Country/Region, 2019 - 2029 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America AN Market Analysis, 2019 - 2029
6.5.1. Latin America AN Market, by Type, 2019 - 2029 (US$ Mn)
6.5.2. Latin America AN Market, by End User, 2019 - 2029 (US$ Mn)
6.5.3. Latin America AN Market, by Country/Region, 2019 - 2029 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa AN Market Analysis, 2019 - 2029
6.6.1. MEA AN Market, by Type, 2019 - 2029 (US$ Mn)
6.6.2. MEA AN Market, by End User, 2019 - 2029 (US$ Mn)
6.6.3. MEA AN Market, by Country/Region, 2019 - 2029 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Becton Dickinson & Company
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Biopsybell Srl
7.3. Cook Medical Incorporated
7.4. CooperSurgical, Inc.
7.5. Laboratoire Ccd
7.6. Medline Industries, Inc.
7.7. Ri.mos. S.r.l.
7.8. Rocket Medical, Plc.
7.9. Smiths Group, Plc.
7.10. Tsunami Medical S.r.l.

Companies Mentioned

  • Becton Dickinson & Company
  • Biopsybell Srl
  • Cook Medical Incorporated
  • CooperSurgical Inc.
  • Laboratoire Ccd.
  • Tsunami Medical S.r.l.
  • Medline Industries Inc.
  • Ri.mos. S.r.l.
  • Smiths Group Plc.
  • Rocket Medical Plc